Profile
Ashraf Amanullah's current job is Chief Technical Operations Officer & Executive VP at Inhibrx Biosciences, Inc. Formerly, Dr. Amanullah worked as Director-Process Development at Genentech, Inc. from 2006 to 2011.
He then served as Senior Director at Gilead Sciences, Inc. from 2011 to 2015.
After that, he held the position of Senior VP-Biologics Development & Manufacturing at aTyr Pharma, Inc. in 2018.
Dr. Amanullah's education includes an undergraduate degree from the University of Birmingham and a doctorate degree from The University of Sheffield.
Ashraf Amanullah active positions
| Companies | Position | Start |
|---|
Former positions of Ashraf Amanullah
| Companies | Position | End |
|---|---|---|
| INHIBRX, INC. | Chief Tech/Sci/R&D Officer | 2024-05-29 |
| ATYR PHARMA, INC. | Corporate Officer/Principal | 2018-06-30 |
| GILEAD SCIENCES, INC. | Director/Board Member | 2015-07-31 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2011-07-31 |
Training of Ashraf Amanullah
| The University of Sheffield | Doctorate Degree |
| University of Birmingham | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| INHIBRX, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Ashraf Amanullah
